Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
-
Source:
Indian Trial of Tranexamic Acid in Spontaneous Intracerebral HaemorrhageSprigg N, Flaherty K, Appleton JP, Al-Shahi Salman R, Bereczki D, Beridze M, Christensen H, Ciccone A, Collins R,
Record details
-
Source:
How Well do we Feed the Critically Ill Patients: a Multicentric, Prospective Observational StudyBloomer MJ, Clarke AB, Morphet J. Nurses' prioritization of enteral nutrition in intensive care
Record details
-
Source:
Structured Trauma Quality Improvement Meetings at Four Trauma Centres in India: Protocol for a Prospective Observational Study to Assess Effectiveness
Record details
-
Source:
Reducing the Burden of Injury in India and Australia Through Development and Piloting of Improved Systems of Care - Prehospital Notification and Structured Handover on Hospital ArrivalMitra B,
Record details
-
Authors :
Guru Subramanian Guru Murthy, Assistant Professor
-
Source:
Phase I Dose Escalation and Expansion Study to Investigate the Safety, Tolerability, and Preliminary Efficacy of Anti-CD30 Bispecific Antibody-armed Anti-CD3-Activated Autologous T-cells (CD30
Record details
-
Authors :
Guru Subramanian Guru Murthy, Assistant Professor
-
Source:
Iadademstat With Hypomethylating Agent in Patients With Myelodysplastic Syndrome
Record details
-
Authors :
Guru Subramanian Guru Murthy, Assistant Professor
-
Source:
Venetoclax-Navitoclax With Cladribine-based Salvage Therapy in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Record details
-
Source:
Living With CKD: An E-Learning Platform for Adolescents With CKD About the Disease and Its Management
Record details
-
Authors :
Narayan (Guru) G. Kowlgi, Principal Investigator
-
Source:
Non-invasive Measurement of Blood Glucose, Blood Pressure and Extrapolation of QRS Complex Using a Wrist Wearable Photoplethysmography Sensor
Record details
-
Source:
Phase II Trial of Lurbinectedin Combined With Avelumab as Switch Maintenance Firstline Therapy for Metastatic Urothelial Carcinoma With Stable or Responding Disease Following Platinum-based
Record details
